BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16:e301-e372. [PMID: 31078652 DOI: 10.1016/j.hrthm.2019.05.007] [Cited by in Crossref: 152] [Cited by in F6Publishing: 124] [Article Influence: 50.7] [Reference Citation Analysis]
Number Citing Articles
1 Gerull B, Brodehl A. Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy. Curr Heart Fail Rep 2021. [PMID: 34478111 DOI: 10.1007/s11897-021-00532-z] [Reference Citation Analysis]
2 Fabritz L, Patten M, Kirchhof P. Taking the heavy load off arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2021;18:1192-3. [PMID: 33878457 DOI: 10.1016/j.hrthm.2021.04.011] [Reference Citation Analysis]
3 Boukens BJ, Nademanee K, Coronel R. Reply: J-Wave Syndromes: Where's the Scar? JACC Clin Electrophysiol 2020;6:1863-4. [PMID: 33357587 DOI: 10.1016/j.jacep.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rawal AS, VanCleave T, Yedlapati N, Saffitz JE, Craigen WJ, Jefferies JL. Arrhythmogenic Ventricular Cardiomyopathy: Challenges With Complex Genetics and Variable Phenotypes. JACC Case Rep 2021;3:438-42. [PMID: 34317553 DOI: 10.1016/j.jaccas.2020.12.012] [Reference Citation Analysis]
5 Simpson J, Anusas J, Oxnard D, Wright S, Mcgowan R, Coats C. Arrhythmogenic Cardiomyopathy—Further Insight into the Clinical Spectrum of Desmoplakin Disease. Cardiogenetics 2021;11:219-29. [DOI: 10.3390/cardiogenetics11040022] [Reference Citation Analysis]
6 Gigli M, Stolfo D, Graw SL, Merlo M, Gregorio C, Nee Chen S, Dal Ferro M, PaldinoMD A, De Angelis G, Brun F, Jirikowic J, Salcedo EE, Turja S, Fatkin D, Johnson R, van Tintelen JP, Te Riele ASJM, Wilde AAM, Lakdawala NK, Picard K, Miani D, Muser D, Maria Severini G, Calkins H, James CA, Murray B, Tichnell C, Parikh VN, Ashley EA, Reuter C, Song J, Judge DP, McKenna WJ, Taylor MRG, Sinagra G, Mestroni L. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants. Circulation 2021;144:1600-11. [PMID: 34587765 DOI: 10.1161/CIRCULATIONAHA.121.053521] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Inoue H, Nakamura S, Higo S, Shiba M, Kohama Y, Kondo T, Kameda S, Tabata T, Okuno S, Ikeda Y, Li J, Liu L, Yamazaki S, Takeda M, Ito E, Takashima S, Miyagawa S, Sawa Y, Hikoso S, Sakata Y. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes. Stem Cell Reports 2022. [DOI: 10.1016/j.stemcr.2021.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Parker LE, Landstrom AP. The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care. Prog Pediatr Cardiol 2021;62:101413. [PMID: 34776723 DOI: 10.1016/j.ppedcard.2021.101413] [Reference Citation Analysis]
9 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Camm AJ, Lip GYH, Schilling R, Calkins H, Steffel J. The year in cardiology: arrhythmias and pacing. Eur Heart J 2020;41:619-625c. [PMID: 31901935 DOI: 10.1093/eurheartj/ehz931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cicenia M, Silvetti MS, Drago F. When Should Premature Ventricular Contractions Be Considered as a Red Flag in Children with Cardiomyopathy? J Cardiovasc Dev Dis 2021;8:176. [PMID: 34940531 DOI: 10.3390/jcdd8120176] [Reference Citation Analysis]
12 Chung MK, Fagerlin A, Wang PJ, Ajayi TB, Allen LA, Baykaner T, Benjamin EJ, Branda M, Cavanaugh KL, Chen LY, Crossley GH, Delaney RK, Eckhardt LL, Grady KL, Hargraves IG, True Hills M, Kalscheur MM, Kramer DB, Kunneman M, Lampert R, Langford AT, Lewis KB, Lu Y, Mandrola JM, Martinez K, Matlock DD, McCarthy SR, Montori VM, Noseworthy PA, Orland KM, Ozanne E, Passman R, Pundi K, Roden DM, Saarel EV, Schmidt MM, Sears SF, Stacey D, Stafford RS, Steinberg BA, Youn Wass S, Wright JM. Shared Decision Making in Cardiac Electrophysiology Procedures and Arrhythmia Management. Circ Arrhythm Electrophysiol 2021;14:e007958. [PMID: 34865518 DOI: 10.1161/CIRCEP.121.007958] [Reference Citation Analysis]
13 Gerull B, Brodehl A. Genetic Animal Models for Arrhythmogenic Cardiomyopathy. Front Physiol 2020;11:624. [PMID: 32670084 DOI: 10.3389/fphys.2020.00624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
14 Hawthorne RN, Blazeski A, Lowenthal J, Kannan S, Teuben R, DiSilvestre D, Morrissette-McAlmon J, Saffitz JE, Boheler KR, James CA, Chelko SP, Tomaselli G, Tung L. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC. J Clin Med 2021;10:3061. [PMID: 34300226 DOI: 10.3390/jcm10143061] [Reference Citation Analysis]
15 Stern LK, Patel J. Cardiac Amyloidosis Treatment. Methodist DeBakey Cardiovascular Journal 2022;18:59-72. [DOI: 10.14797/mdcvj.1050] [Reference Citation Analysis]
16 Cappelletto C, Stolfo D. Reply to the Letter to the Editor entitled “The importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia”. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.04.087] [Reference Citation Analysis]
17 Shah MJ, Silka MJ, Silva JNA, Balaji S, Beach CM, Benjamin MN, Berul CI, Cannon B, Cecchin F, Cohen MI, Dalal AS, Dechert BE, Foster A, Gebauer R, Gonzalez Corcia MC, Kannankeril PJ, Karpawich PP, Kim JJ, Krishna MR, Kubuš P, LaPage MJ, Mah DY, Malloy-Walton L, Miyazaki A, Motonaga KS, Niu MC, Olen M, Paul T, Rosenthal E, Saarel EV, Silvetti MS, Stephenson EA, Tan RB, Triedman J, Bergen NHV, Wackel PL; Writing Committee Members. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clin Electrophysiol 2021;7:1437-72. [PMID: 34794667 DOI: 10.1016/j.jacep.2021.07.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hagiwara H, Watanabe M, Kamada R, Koya T, Nakao M, Anzai T. Epsilon wave disappearance by catheter ablation for ventricular arrhythmia from the left ventricular outflow tract. HeartRhythm Case Rep 2021;7:343-6. [PMID: 34026529 DOI: 10.1016/j.hrcr.2021.02.012] [Reference Citation Analysis]
19 Crescenzi C, Panattoni G, Stazi A, Martino A, Sgueglia M, De Ruvo E, Calò L. Ventricular arrhythmias and risk stratification of cardiac sudden death in athletes. Minerva Cardioangiol 2020;68:110-22. [PMID: 32429629 DOI: 10.23736/S0026-4725.20.05178-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Reuter CM, Dries AM, Parikh VN. Arrhythmogenic Cardiomyopathy: Mechanisms, Genetics, and Their Clinical Implications. Curr Cardiovasc Risk Rep 2021;15. [DOI: 10.1007/s12170-021-00669-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Patel V, Asatryan B, Siripanthong B, Munroe PB, Tiku-Owens A, Lopes LR, Khanji MY, Protonotarios A, Santangeli P, Muser D, Marchlinski FE, Brady PA, Chahal CAA. State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy. Int J Mol Sci 2020;21:E6615. [PMID: 32927679 DOI: 10.3390/ijms21186615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Zhai L, Hu Y, Li X, Zhang X, Gu Z, Zhao Z, Yang X. Incidence, Predictors and Clinical Impact of Ventricular Electrical Storm in Arrhythmogenic Cardiomyopathy Patients with an Implantable Cardioverter-Defibrillator: A Single-Center Report with Medium-Term Follow-Up. Int J Gen Med 2021;14:10055-63. [PMID: 34984026 DOI: 10.2147/IJGM.S345872] [Reference Citation Analysis]
23 Moreno Madrid JM. Circulation and Contacts in Sixteenth Century New Cartography: Spain, Portugal and Italy. Cult Hist Digit J 2021;10:e015. [DOI: 10.3989/chdj.2021.015] [Reference Citation Analysis]
24 Agbaedeng TA, Roberts KA, Colley L, Noubiap JJ, Oxborough D. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis. Europace 2022:euac014. [PMID: 35298614 DOI: 10.1093/europace/euac014] [Reference Citation Analysis]
25 Caruso MR, Garg L, Martinez MW. Cardiac Imaging in the Athlete: Shrinking the "Gray Zone". Curr Treat Options Cardiovasc Med 2020;22:5. [PMID: 32016641 DOI: 10.1007/s11936-020-0802-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Cvijic M, Rib Y, Danojevic S, Radulescu CI, Nazghaidze N, Vardas P. Heart failure with mildly reduced ejection fraction: from diagnosis to treatment. Gaps and dilemmas in current clinical practice. Heart Fail Rev. [DOI: 10.1007/s10741-022-10267-1] [Reference Citation Analysis]
27 Gonzalez Corcia MC, Motonaga KS. Pediatric Arrhythmogenic Right Ventricular Cardiomyopathy: They May Be Small, But They Pack a Big Punch. JACC Clin Electrophysiol 2022;8:319-21. [PMID: 35331426 DOI: 10.1016/j.jacep.2021.09.014] [Reference Citation Analysis]
28 Baudinaud P, Laredo M, Badenco N, Rouanet S, Waintraub X, Duthoit G, Hidden-Lucet F, Redheuil A, Maupain C, Gandjbakhch E. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy. Can J Cardiol 2021;37:1263-6. [PMID: 33675936 DOI: 10.1016/j.cjca.2021.02.018] [Reference Citation Analysis]
29 Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev 2021. [PMID: 34263412 DOI: 10.1007/s10741-021-10139-0] [Reference Citation Analysis]
30 Pecorari I, Mestroni L, Sbaizero O. Current Understanding of the Role of Cytoskeletal Cross-Linkers in the Onset and Development of Cardiomyopathies. Int J Mol Sci 2020;21:E5865. [PMID: 32824180 DOI: 10.3390/ijms21165865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Heliö K, Mäyränpää MI, Saarinen I, Ahonen S, Junnila H, Tommiska J, Weckström S, Holmström M, Toivonen M, Nikus K, Hathaway J, Siivonen P, Muona M, Sistonen J, Salmenperä P, Gentile M, Paananen J, Myllykangas S, Alastalo TP, Heliö T, Koskenvuo J. GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy. Front Genet 2021;12:786705. [PMID: 34899865 DOI: 10.3389/fgene.2021.786705] [Reference Citation Analysis]
32 Monda E, Lioncino M, Rubino M, Caiazza M, Cirillo A, Fusco A, Pacileo R, Fimiani F, Amodio F, Borrelli N, Colonna D, D'Onofrio B, Frisso G, Drago F, Castelletti S, Sarubbi B, Calabrò P, Russo MG, Limongelli G. The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention. Heart Fail Clin 2022;18:115-23. [PMID: 34776073 DOI: 10.1016/j.hfc.2021.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
33 Bleijendaal H, Ramos LA, Lopes RR, Verstraelen TE, Baalman SWE, Oudkerk Pool MD, Tjong FVY, Melgarejo-Meseguer FM, Gimeno-Blanes FJ, Gimeno-Blanes JR, Amin AS, Winter MM, Marquering HA, Kok WEM, Zwinderman AH, Wilde AAM, Pinto YM. Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram? Heart Rhythm 2021;18:79-87. [PMID: 32911053 DOI: 10.1016/j.hrthm.2020.08.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 James CA, Calkins H. Arrhythmogenic right ventricular cardiomyopathy: evidence for progression increases. European Heart Journal 2020;41:1411-3. [DOI: 10.1093/eurheartj/ehz705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Abicht A, Schön U, Laner A, Holinski-Feder E, Diebold I. Actionable secondary findings in arrhythmogenic right ventricle cardiomyopathy genes: impact and challenge of genetic counseling. Cardiovasc Diagn Ther 2021;11:637-49. [PMID: 33968641 DOI: 10.21037/cdt-20-585] [Reference Citation Analysis]
36 Pătru AE, Onciul S, Sturzu A, Cinteză E, Gima E, Popescu BA, Chevalier P, Jurcuț R. Acute Myocarditis-Like Episode in a Curly-Haired Young Boy-Red Flags for Familial Arrhythmogenic Cardiomyopathy. Diagnostics (Basel) 2020;10:E651. [PMID: 32878047 DOI: 10.3390/diagnostics10090651] [Reference Citation Analysis]
37 Palermi S, Serio A, Vecchiato M, Sirico F, Gambardella F, Ricci F, Iodice F, Radmilovic J, Russo V, D'Andrea A. Potential role of an athlete-focused echocardiogram in sports eligibility. World J Cardiol 2021; 13(8): 271-297 [PMID: 34589165 DOI: 10.4330/wjc.v13.i8.271] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
38 Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, Stolfo D, Haywood ME, Dal Ferro M, Altinier A, Ramani F, Brun F, Cocciolo A, Puggia I, Morea G, McKenna WJ, La Rosa FG, Taylor MRG, Sinagra G, Mestroni L. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol 2019;74:1480-90. [PMID: 31514951 DOI: 10.1016/j.jacc.2019.06.072] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 32.0] [Reference Citation Analysis]
39 Carruth ED, Beer D, Alsaid A, Schwartz MLB, McMinn M, Kelly MA, Buchanan AH, Nevius CD, Calkins H, James CA, Murray B, Tichnell C, Matsumura ME, Kirchner HL, Fornwalt BK, Sturm AC, Haggerty CM. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants. Circ Genom Precis Med 2021;14:e003302. [PMID: 33684294 DOI: 10.1161/CIRCGEN.120.003302] [Reference Citation Analysis]
40 Volpato G, Falanga U, Cipolletta L, Conti MA, Grifoni G, Ciliberti G, Urbinati A, Barbarossa A, Stronati G, Fogante M, Bergonti M, Catto V, Guerra F, Giovagnoni A, Dello Russo A, Casella M, Compagnucci P. Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases. Medicina (Kaunas) 2021;57:308. [PMID: 33805943 DOI: 10.3390/medicina57040308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Popa-Fotea NM, Cojocaru C, Scafa-Udriste A, Micheu MM, Dorobantu M. The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies. J Clin Med. 2020;9. [PMID: 32635562 DOI: 10.3390/jcm9072111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Bueno-Beti C, Asimaki A. Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy. Front Cardiovasc Med 2021;8:746321. [PMID: 34950711 DOI: 10.3389/fcvm.2021.746321] [Reference Citation Analysis]
43 Kim EJ, Holmes BB, Huang S, Lugo R, Al Aboud A, Goodman S, Hung RR, Slosky D, Stevenson WG, Michaud GF, John RM. Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator. Europace 2020;22:1216-23. [PMID: 32514579 DOI: 10.1093/europace/euaa094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
44 Love CJ. Current Guidelines and Clinical Practice. Card Electrophysiol Clin 2021;13:459-71. [PMID: 34330373 DOI: 10.1016/j.ccep.2021.05.003] [Reference Citation Analysis]
45 Corianò M, Tona F. Strategies for Sudden Cardiac Death Prevention. Biomedicines 2022;10:639. [DOI: 10.3390/biomedicines10030639] [Reference Citation Analysis]
46 Silka MJ, Shah MJ, Silva JNA, Balaji S, Beach CM, Benjamin MN, Berul CI, Cannon B, Cecchin F, Cohen MI, Dalal AS, Dechert BE, Foster A, Gebauer R, Gonzalez Corcia MC, Kannakeril PJ, Karpawich PP, Kim JJ, Krishna MR, Kubuš P, LaPage MJ, Mah DY, Malloy-Walton L, Miyazaki A, Motonaga KS, Niu MC, Olen M, Paul T, Rosenthal E, Saarel EV, Silvetti MS, Stephenson EA, Tan RB, Triedman J, Von Bergen NH, Wackel PL; Document Reviewers: Philip M. Chang, Fabrizio Drago, Anne M. Dubin, Susan P. Etheridge, Apichai Kongpatanayothin, Jose Manuel Moltedo, Ashish A. Nabar and George F. Van Hare. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary. Cardiol Young 2021;31:1717-37. [PMID: 34796795 DOI: 10.1017/S1047951121003395] [Reference Citation Analysis]
47 Chimenti C, Lavalle C, Magnocavallo M, Alfarano M, Mariani MV, Bernardini F, Della Rocca DG, Galardo G, Severino P, Di Lullo L, Miraldi F, Fedele F, Frustaci A. A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy. ESC Heart Fail 2021. [PMID: 34918480 DOI: 10.1002/ehf2.13694] [Reference Citation Analysis]
48 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart Rhythm 2020;17:e269-316. [PMID: 32553607 DOI: 10.1016/j.hrthm.2020.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite LR, Al-Khatib SM, Anter E, Berruezo A, Callans DJ, Chung MK, Cuculich P, d'Avila A, Deal BJ, Bella PD, Deneke T, Dickfeld TM, Hadid C, Haqqani HM, Kay GN, Latchamsetty R, Marchlinski F, Miller JM, Nogami A, Patel AR, Pathak RK, Saenz Morales LC, Santangeli P, Sapp JL Jr, Sarkozy A, Soejima K, Stevenson WG, Tedrow UB, Tzou WS, Varma N, Zeppenfeld K. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. J Interv Card Electrophysiol 2020;59:145-298. [PMID: 31984466 DOI: 10.1007/s10840-019-00663-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lüsebrink E, Binzenhöfer L, Brunner S, Hausleiter J, Massberg S, Orban M, Kääb S. How exercise can deteriorate the clinical course of an ARVC patient: a case report. Eur Heart J Case Rep 2021;5:ytab417. [PMID: 34816084 DOI: 10.1093/ehjcr/ytab417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hylind RJ, Abrams DJ. Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Heart Assoc 2020;9:e015702. [PMID: 32009530 DOI: 10.1161/JAHA.119.015702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Monda E, Blasi E, De Pasquale A, Di Vilio A, Amodio F, Caiazza M, Diana G, Lioncino M, Perna A, Verrillo F, Martucci ML, Munciguerra O, Vergara A, Limongelli G. Clinical and Molecular Characteristics of Patients with PLN R14del Cardiomyopathy: State-of-the-Art Review. Cardiogenetics 2022;12:112-21. [DOI: 10.3390/cardiogenetics12010012] [Reference Citation Analysis]
53 Zhang N, Wang C, Gasperetti A, Song Y, Niu H, Gu M, Duru F, Chen L, Zhang S, Hua W. Validation of an Arrhythmogenic Right Ventricular Cardiomyopathy Risk-Prediction Model in a Chinese Cohort. JCM 2022;11:1973. [DOI: 10.3390/jcm11071973] [Reference Citation Analysis]
54 Wichter T, Milberg P, Wichter HD, Dechering DG. Pregnancy in arrhythmogenic cardiomyopathy. Herzschrittmacherther Elektrophysiol 2021;32:186-98. [PMID: 34032905 DOI: 10.1007/s00399-021-00770-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Jordà P, Bosman LP, Gasperetti A, Mazzanti A, Gourraud JB, Davies B, Frederiksen TC, Moreno Weidmann Z, Di Marco A, Roberts JD, MacIntyre C, Seifer C, Delinière A, Alqarawi W, Kukavica D, Minois D, Trancuccio A, Arnaud M, Targetti M, Martino A, Oliviero G, Pipilas DC, Carbucicchio C, Compagnucci P, Dello Russo A, Olivotto I, Calò L, Lubitz SA, Cutler MJ, Chevalier P, Arbelo E, Priori SG, Healey JS, Calkins H, Casella M, Jensen HK, Tondo C, Tadros R, James CA, Krahn AD, Cadrin-Tourigny J. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator. Eur Heart J 2022:ehac289. [PMID: 35766180 DOI: 10.1093/eurheartj/ehac289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lin YN, Mesquita T, Sanchez L, Chen YH, Liu W, Li C, Rogers R, Wang Y, Li X, Wu D, Zhang R, Ibrahim A, Marbán E, Cingolani E. Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice. Eur Heart J 2021:ehab419. [PMID: 34345905 DOI: 10.1093/eurheartj/ehab419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Hammersley DJ, Halliday BP. Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach. Curr Cardiol Rep 2020;22:85. [PMID: 32648053 DOI: 10.1007/s11886-020-01343-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Castrichini M, Eldemire R, Groves DW, Taylor MR, Miyamoto S, Mestroni L. Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective. Prog Pediatr Cardiol 2021;63:101459. [PMID: 34970070 DOI: 10.1016/j.ppedcard.2021.101459] [Reference Citation Analysis]
59 Domínguez F, Lalaguna L, López-Olañeta M, Villalba-Orero M, Padrón-Barthe L, Román M, Bello-Arroyo E, Briceño A, Gonzalez-Lopez E, Segovia-Cubero J, García-Pavía P, Lara-Pezzi E. Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5. Circ Heart Fail 2021;14:e007616. [PMID: 34412508 DOI: 10.1161/CIRCHEARTFAILURE.120.007616] [Reference Citation Analysis]
60 Śpiewak M, Kłopotowski M, Małek ŁA, Lipczyńska M, Marczak M. Cardiac Lipomatosis: A Rare Form of Left Ventricular Hypertrophy. Can J Cardiol 2020:S0828-282X(20)31109-0. [PMID: 33249125 DOI: 10.1016/j.cjca.2020.11.008] [Reference Citation Analysis]
61 Sharif ZI, Lubitz SA. Ventricular arrhythmia management in patients with genetic cardiomyopathies. Heart Rhythm O2 2021;2:819-31. [PMID: 34988533 DOI: 10.1016/j.hroo.2021.10.009] [Reference Citation Analysis]
62 Haugaa KH. Exercise and detraining are modifiable factors for arrhythmic risk in arrhythmogenic cardiomyopathy needing correct dosage. Heart Rhythm 2020;17:1260-1. [PMID: 32247014 DOI: 10.1016/j.hrthm.2020.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Chen SN, Mestroni L, Taylor MRG. Genetics of dilated cardiomyopathy. Curr Opin Cardiol 2021;36:288-94. [PMID: 33769382 DOI: 10.1097/HCO.0000000000000845] [Reference Citation Analysis]
64 Bosman LP, Te Riele ASJM. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification. Heart 2021:heartjnl-2021-319113. [PMID: 33990412 DOI: 10.1136/heartjnl-2021-319113] [Reference Citation Analysis]
65 Anys S, Billon C, Mazzella JM, Karam N, Pechmajou L, Youssfi Y, Bellenfant F, Jost D, Jabre P, Soulat G, Bruneval P, Weizman O, Varlet E, Baudinaud P, Dumas F, Bougouin W, Cariou A, Lavergne T, Wahbi K, Jouven X, Marijon E. [Fighting against unexplained sudden death]. Ann Cardiol Angeiol (Paris) 2021;70:129-35. [PMID: 33972104 DOI: 10.1016/j.ancard.2021.03.002] [Reference Citation Analysis]
66 Rella V, Parati G, Crotti L. Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators. Front Pediatr 2020;8:139. [PMID: 32318526 DOI: 10.3389/fped.2020.00139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, Agarwal PP, Arscott P, Dellefave-Castillo LM, Vorovich EE, Nutakki K, Wilsbacher LD, Priori SG, Jacoby DL, McNally EM, Helms AS. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation 2020;141:1872-84. [PMID: 32372669 DOI: 10.1161/CIRCULATIONAHA.119.044934] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 25.0] [Reference Citation Analysis]
68 Roudijk RW, Verheul L, Bosman LP, Bourfiss M, Breur JMPJ, Slieker MG, Blank AC, Dooijes D, van der Heijden JF, van den Heuvel F, Clur SA, Udink Ten Cate FEA, van den Berg MP, Wilde AAM, Asselbergs FW, Peter van Tintelen J, Te Riele ASJM. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy. JACC Clin Electrophysiol 2022;8:306-18. [PMID: 35331425 DOI: 10.1016/j.jacep.2021.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Casella M, Dello Russo A, Bergonti M, Catto V, Conte E, Sommariva E, Gasperetti A, Vettor G, Tundo F, Sicuso R, Rizzo S, Mushtaq S, Della Rocca D, Pompilio G, Di Biase L, Andreini D, Natale A, Basso C, Tondo C. Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies. Circulation 2020;142:1249-60. [PMID: 32791857 DOI: 10.1161/CIRCULATIONAHA.120.046900] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
70 Malik N, Mukherjee M, Wu KC, Zimmerman SL, Zhan J, Calkins H, James CA, Gilotra NA, Sheikh FH, Tandri H, Kutty S, Hays AG. Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Imaging 2022;15:e013725. [PMID: 35147040 DOI: 10.1161/CIRCIMAGING.121.013725] [Reference Citation Analysis]
71 Njoroge JN, Mangena JC, Aribeana C, Parikh VN. Emerging Genotype-Phenotype Associations in Dilated Cardiomyopathy. Curr Cardiol Rep 2022. [PMID: 35900642 DOI: 10.1007/s11886-022-01727-z] [Reference Citation Analysis]
72 Yao JV, Peters S, Zentner D, James P, Voukelatos J, Kalman J. Emerging role of genetic analysis for stratification of sudden cardiac death risk in dilated cardiomyopathy: An illustrative case. HeartRhythm Case Rep 2020;6:499-502. [PMID: 32817827 DOI: 10.1016/j.hrcr.2020.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Simões MV, Fernandes F, Marcondes-Braga FG, Scheinberg P, Correia EB, Rohde LEP, Bacal F, Alves SMM, Mangini S, Biolo A, Beck-da-Silva L, Szor RS, Marques Junior W, Oliveira ASB, Cruz MW, Bueno BVK, Hajjar LA, Issa AFC, Ramires FJA, Coelho Filho OR, Schmidt A, Pinto IMF, Rochitte CE, Vieira MLC, Mesquita CT, Ramos CD, Soares-Junior J, Romano MMD, Mathias Junior W, Garcia Junior MI, Montera MW, Melo MDT, Silva SME, Garibaldi PMM, Alencar Neto AC, Lopes RD, Ávila DX, Viana D, Saraiva JFK, Canesin MF, Oliveira GMM, Mesquita ET. Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021. Arq Bras Cardiol 2021;117:561-98. [PMID: 34550244 DOI: 10.36660/abc.20210718] [Reference Citation Analysis]
74 Cadrin-Tourigny J, Bosman LP, Tadros R, Talajic M, Rivard L, James CA, Khairy P. Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update. Expert Rev Cardiovasc Ther 2019;17:645-51. [PMID: 31422711 DOI: 10.1080/14779072.2019.1657831] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Zorzi A, Cipriani A, Bariani R, Pilichou K, Corrado D, Bauce B. Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy. Curr Cardiol Rep 2021;23:57. [PMID: 33961139 DOI: 10.1007/s11886-021-01489-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Mattesi G, Zorzi A, Corrado D, Cipriani A. Natural History of Arrhythmogenic Cardiomyopathy. J Clin Med 2020;9:E878. [PMID: 32210158 DOI: 10.3390/jcm9030878] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
77 Fatkin D, Calkins H, Elliott P, James CA, Peters S, Kovacic JC. Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies: JACC Focus Seminar 3/5. J Am Coll Cardiol 2021;77:2551-72. [PMID: 34016267 DOI: 10.1016/j.jacc.2020.12.072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kandhari N, Khoury S, Behr ER, Miles C. Cardiac arrest as first presentation of arrhythmogenic left ventricular cardiomyopathy due to Filamin C mutation: a case report. Eur Heart J Case Rep 2021;5:ytab422. [PMID: 34993393 DOI: 10.1093/ehjcr/ytab422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 124] [Cited by in F6Publishing: 33] [Article Influence: 124.0] [Reference Citation Analysis]
80 Johnson JN, Loriaux DB, Jenista E, Kim HW, Baritussio A, De Garate Iparraguirre E, Bucciarelli-Ducci C, Denny V, O'Connor B, Siddiqui S, Fujikura K, Benton CW, Weinsaft JW, Kochav J, Kim J, Madamanchi C, Steigner M, Kwong R, Chango-Azanza D, Chapa M, Rosales-Uvera S, Sitwala P, Filev P, Sahu A, Craft J, Punnakudiyil GJ, Jayam V, Shams F, Hughes SG, Lee JCY, Hulten EA, Steel KE, Chen SSM. Society for Cardiovascular Magnetic Resonance 2021 cases of SCMR and COVID-19 case collection series. J Cardiovasc Magn Reson 2022;24:42. [PMID: 35787291 DOI: 10.1186/s12968-022-00872-2] [Reference Citation Analysis]
81 Asatryan B, Marcus FI. The Ever-Expanding Landscape of Cardiomyopathies. JACC Case Rep 2020;2:361-4. [PMID: 34319296 DOI: 10.1016/j.jaccas.2020.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Ghidoni A, Elliott PM, Syrris P, Calkins H, James CA, Judge DP, Murray B, Barc J, Probst V, Schott JJ, Song JP, Hauer RNW, Hoorntje ET, van Tintelen JP, Schulze-Bahr E, Hamilton RM, Mittal K, Semsarian C, Behr ER, Ackerman MJ, Basso C, Parati G, Gentilini D, Kotta MC, Mayosi BM, Schwartz PJ, Crotti L. Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features. Circ Genom Precis Med 2021;14:e003097. [PMID: 33566628 DOI: 10.1161/CIRCGEN.120.003097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
83 Bosman LP, Nielsen Gerlach CL, Cadrin-Tourigny J, Orgeron G, Tichnell C, Murray B, Bourfiss M, van der Heijden JF, Yap SC, Zeppenfeld K, van den Berg MP, Wilde AAM, Asselbergs FW, Tandri H, Calkins H, van Tintelen JP, James CA, Te Riele ASJM. Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy. Europace 2021:euab162. [PMID: 34468736 DOI: 10.1093/europace/euab162] [Reference Citation Analysis]
84 Otto CM. Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections. Heart 2022;108:83-5. [PMID: 34937799 DOI: 10.1136/heartjnl-2021-320691] [Reference Citation Analysis]
85 Florio MT, Boccia F, Vetrano E, Borrelli M, Gossios T, Palmiero G. Pathogenesis, Diagnosis and Risk Stratification in Arrhythmogenic Cardiomyopathy. Cardiogenetics 2021;11:263-89. [DOI: 10.3390/cardiogenetics11040025] [Reference Citation Analysis]
86 Moccia E, Papatheodorou E, Miles CJ, Merghani A, Malhotra A, Dhutia H, Bastiaenen R, Sheikh N, Zaidi A, Sanna GD, Homfray T, Bunce N, Anderson LJ, Tome M, Behr E, Moon J, Sharma S, Finocchiaro G, Papadakis M. Arrhythmogenic cardiomyopathy and differential diagnosis with physiological right ventricular remodelling in athletes using cardiovascular magnetic resonance. Int J Cardiovasc Imaging. [DOI: 10.1007/s10554-022-02684-y] [Reference Citation Analysis]
87 Stolfo D, Collini V, Sinagra G. Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis. Heart Fail Clin 2021;17:661-72. [PMID: 34511213 DOI: 10.1016/j.hfc.2021.05.010] [Reference Citation Analysis]
88 Papanikolaou IC, Antonakis E, Pandi A. State-of-the-Art Treatments for Sarcoidosis. Methodist DeBakey Cardiovascular Journal 2022;18:94-105. [DOI: 10.14797/mdcvj.1068] [Reference Citation Analysis]
89 Aquaro GD, De Luca A, Cappelletto C, Raimondi F, Bianco F, Botto N, Barison A, Romani S, Lesizza P, Fabris E, Todiere G, Grigoratos C, Pingitore A, Stolfo D, Dal Ferro M, Merlo M, Di Bella G, Sinagra G. Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy. ESC Heart Fail 2020. [PMID: 32965795 DOI: 10.1002/ehf2.13019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Shah MJ, Silka MJ, Silva JA, Balaji S, Beach C, Benjamin M, Berul C, Cannon B, Cecchin F, Cohen M, Dalal A, Dechert B, Foster A, Gebauer R, Gonzalez Corcia MC, Kannankeril P, Karpawich P, Kim J, Krishna MR, Kubuš P, Malloy-Walton L, LaPage M, Mah D, Miyazaki A, Motonaga K, Niu M, Olen M, Paul T, Rosenthal E, Saarel E, Silvetti MS, Stephenson E, Tan R, Triedman J, Von Bergen N, Wackel P; Writing Committee Members., Document Reviewers. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Indian Pacing Electrophysiol J 2021:S0972-6292(21)00115-7. [PMID: 34333141 DOI: 10.1016/j.ipej.2021.07.005] [Reference Citation Analysis]
91 Muñoz Moreno JM, Holguin Palacios C, Lobato Jeri C, Reyes Villanes S, Peralta Ramos W, Reyes Rocha M. Non-Compaction Cardiomyopathy and Multiple Sclerosis: Associated or Independent Diseases? A Case Report. Front Cardiovasc Med 2022;9:871350. [DOI: 10.3389/fcvm.2022.871350] [Reference Citation Analysis]
92 Mckenna WJ, Caforio AL. Myocardial inflammation and sudden death in the inherited cardiomyopathies. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Reza N, de Feria A, Chowns JL, Hoffman-andrews L, Vann L, Kim J, Marzolf A, Owens AT. Cardiovascular Characteristics of Patients with Genetic Variation in Desmoplakin (DSP). Cardiogenetics 2022;12:24-36. [DOI: 10.3390/cardiogenetics12010003] [Reference Citation Analysis]
94 Mages C, Gampp H, Syren P, Rahm AK, André F, Frey N, Lugenbiel P, Thomas D. Electrical Ventricular Remodeling in Dilated Cardiomyopathy. Cells 2021;10:2767. [PMID: 34685747 DOI: 10.3390/cells10102767] [Reference Citation Analysis]
95 Silka MJ, Shah MJ, Silva JA, Balaji S, Beach C, Benjamin M, Berul C, Cannon B, Cecchin F, Cohen M, Dalal A, Dechert B, Foster A, Gebauer R, Gonzalez Corcia MC, Kannankeril P, Karpawich P, Kim J, Krishna MR, Kubuš P, Malloy-Walton L, LaPage M, Mah D, Miyazaki A, Motonaga K, Niu M, Olen M, Paul T, Rosenthal E, Saarel E, Silvetti MS, Stephenson E, Tan R, Triedman J, Von Bergen N, Wackel P; Writing Committee Members., Document Reviewers. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Indian Pacing Electrophysiol J 2021:S0972-6292(21)00116-9. [PMID: 34333142 DOI: 10.1016/j.ipej.2021.07.006] [Reference Citation Analysis]
96 Huang W, Xu R, Gao N, Wu X, Wen C. Case Report: Family Curse: An SCN5A Mutation, c.611C>A, p.A204E Associated With a Family History of Dilated Cardiomyopathy and Arrhythmia. Front Cardiovasc Med 2022;9:822150. [DOI: 10.3389/fcvm.2022.822150] [Reference Citation Analysis]
97 Ortiz-Genga M, García-Hernández S, Monserrat-Iglesias L, McKenna WJ. Preventing Sudden Death in Arrhythmogenic Cardiomyopathy: Careful Family and Genetic Evaluation Key to Appropriate Diagnosis and Management. Can J Cardiol 2021;37:819-21. [PMID: 33359000 DOI: 10.1016/j.cjca.2020.12.013] [Reference Citation Analysis]
98 Zegkos T, Panagiotidis T, Parcharidou D, Efthimiadis G. Emerging concepts in arrhythmogenic dilated cardiomyopathy. Heart Fail Rev 2021;26:1219-29. [PMID: 32056050 DOI: 10.1007/s10741-020-09933-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
99 O’sullivan JW, Rhee J, Hsu D, Wheeler MT, Nieman K. Multimodality Imaging for Risk Assessment of Inherited Cardiomyopathies. Curr Cardiovasc Risk Rep 2020;14. [DOI: 10.1007/s12170-020-0639-4] [Reference Citation Analysis]
100 Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, Chugh SS, Cornel MC, Gardner K, Ingles J, James CA, Jimmy Juang JM, Kääb S, Kaufman ES, Krahn AD, Lubitz SA, MacLeod H, Morillo CA, Nademanee K, Probst V, Saarel EV, Sacilotto L, Semsarian C, Sheppard MN, Shimizu W, Skinner JR, Tfelt-Hansen J, Wang DW. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm 2021;18:e1-e50. [PMID: 33091602 DOI: 10.1016/j.hrthm.2020.10.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
101 Lopes RR, Bleijendaal H, Ramos LA, Verstraelen TE, Amin AS, Wilde AAM, Pinto YM, de Mol BAJM, Marquering HA. Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers. Comput Biol Med 2021;131:104262. [PMID: 33607378 DOI: 10.1016/j.compbiomed.2021.104262] [Reference Citation Analysis]
102 Allwood RP. Differentiating right ventricular remodelling from cardiac pathology in athletes. Sonography. [DOI: 10.1002/sono.12299] [Reference Citation Analysis]
103 Sasaki S, Nishizaki K, Ishida Y, Toyama Y, Hamaura S, Tomita H. Usefulness of lead repositioning to improve subcutaneous electrocardiogram sensing in patients with arrhythmogenic right ventricular cardiomyopathy with subcutaneous implantable cardioverter-defibrillator. HeartRhythm Case Rep 2020;6:786-90. [PMID: 33101956 DOI: 10.1016/j.hrcr.2020.07.023] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Woźniak O, Borowiec K, Konka M, Cicha-Mikołajczyk A, Przybylski A, Szumowski Ł, Hoffman P, Poślednik K, Biernacka EK. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy. Heart 2021:heartjnl-2020-318415. [PMID: 33674353 DOI: 10.1136/heartjnl-2020-318415] [Reference Citation Analysis]
105 Beffagna G, Sommariva E, Bellin M. Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models. Front Physiol 2020;11:568535. [PMID: 33281612 DOI: 10.3389/fphys.2020.568535] [Reference Citation Analysis]
106 Chen SN, Sbaizero O, Taylor MRG, Mestroni L. Lamin A/C Cardiomyopathy: Implications for Treatment. Curr Cardiol Rep 2019;21:160. [PMID: 31773301 DOI: 10.1007/s11886-019-1224-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
107 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 209] [Cited by in F6Publishing: 73] [Article Influence: 209.0] [Reference Citation Analysis]
108 Wang W, Tichnell C, Murray BA, Agafonova J, Cadrin-tourigny J, Chelko S, Tandri H, Calkins H, James CA. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients. EP Europace 2020;22:1270-8. [DOI: 10.1093/europace/euaa105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
109 Shen LS, Liu LM, Zheng LH, Hu F, Hu ZC, Liu SY, Guo JR, Bhagat KK, Yao Y. Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis. J Geriatr Cardiol 2020;17:694-703. [PMID: 33343648 DOI: 10.11909/j.issn.1671-5411.2020.11.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Stege NM, de Boer RA, van den Berg MP, Silljé HHW. The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies. Int J Mol Sci 2021;22:2955. [PMID: 33799487 DOI: 10.3390/ijms22062955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Liżewska-Springer A, Sławiński G, Lewicka E. Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis-A Narrative Literature Review. J Clin Med 2021;10:1858. [PMID: 33922892 DOI: 10.3390/jcm10091858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace 2020;22:1147-8. [PMID: 32538434 DOI: 10.1093/europace/euaa065] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
113 Tanaka TD, Suzuki T, Marcus FI. Sustained Wide Complex Tachycardia in a Healthy Man. JAMA Intern Med 2021. [PMID: 34369979 DOI: 10.1001/jamainternmed.2021.3512] [Reference Citation Analysis]
114 Ingles J, Macciocca I, Morales A, Thomson K. Genetic Testing in Inherited Heart Diseases. Heart Lung Circ 2020;29:505-11. [PMID: 31813745 DOI: 10.1016/j.hlc.2019.10.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
115 Lachaize V, Peña B, Ciubotaru C, Cojoc D, Chen SN, Taylor MRG, Mestroni L, Sbaizero O. Compromised Biomechanical Properties, Cell-Cell Adhesion and Nanotubes Communication in Cardiac Fibroblasts Carrying the Lamin A/C D192G Mutation. Int J Mol Sci 2021;22:9193. [PMID: 34502098 DOI: 10.3390/ijms22179193] [Reference Citation Analysis]
116 Oliveira MT Jr, Villacorta H, Bittencourt MI, Barretto ACP, Mesquita ET, Rohde LE. Emerging Topics in Heart Failure: Future Perspectives. Arq Bras Cardiol 2020;115:1197-200. [PMID: 33470325 DOI: 10.36660/abc.20201205] [Reference Citation Analysis]
117 Asatryan B, Chahal CAA. Enhancing risk stratification for life-threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine. ESC Heart Fail 2020;7:1383-6. [PMID: 32643283 DOI: 10.1002/ehf2.12886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
118 Gasperetti A, Cappelletto C, Carrick R, Targetti M, Tichnell C, Martino A, Murray B, Compagnucci P, Stolfo D, Bisson J, Gilotra N, Carbucicchio C, Olivotto I, Tandri H, Dello Russo A, Cadrin-Tourigny J, Calò L, Tondo C, Sinagra G, James CA, Casella M, Calkins H. Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. JAMA Cardiol 2022. [PMID: 35195686 DOI: 10.1001/jamacardio.2021.6016] [Reference Citation Analysis]
119 Rao RA, Jawaid O, Janish C, Raman SV. When to Use Cardiovascular Magnetic Resonance in Patients with Heart Failure. Heart Fail Clin 2021;17:1-8. [PMID: 33220878 DOI: 10.1016/j.hfc.2020.09.001] [Reference Citation Analysis]
120 Gasperetti A, Rossi VA, Chiodini A, Casella M, Costa S, Akdis D, Büchel R, Deliniere A, Pruvot E, Gruner C, Carbucicchio C, Manka R, Dello Russo A, Tondo C, Brunckhorst C, Tanner F, Duru F, Saguner AM. Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria. Heart Rhythm 2021;18:231-8. [PMID: 32976989 DOI: 10.1016/j.hrthm.2020.09.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
121 Marstrand P, Picard K, Lakdawala NK. Second Hits in Dilated Cardiomyopathy. Curr Cardiol Rep 2020;22. [DOI: 10.1007/s11886-020-1260-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
122 Wallace R, Calkins H. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Arrhythm Electrophysiol Rev 2021;10:26-32. [PMID: 33936740 DOI: 10.15420/aer.2020.39] [Reference Citation Analysis]
123 Keil L, Chevalier C, Kirchhof P, Blankenberg S, Lund G, Müllerleile K, Magnussen C. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy. Int J Mol Sci 2021;22:7115. [PMID: 34281168 DOI: 10.3390/ijms22137115] [Reference Citation Analysis]
124 Lie ØH, Chivulescu M, Rootwelt-Norberg C, Ribe M, Bogsrud MP, Lyseggen E, Beitnes JO, Almaas V, Haugaa KH. Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis. J Am Heart Assoc 2021;10:e018680. [PMID: 33821670 DOI: 10.1161/JAHA.120.018680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
125 Khosla J, Golamari R, Cai A, Benson J, Aronow WS, Jain R, Jain R. Evidence-based management of arrhythmogenic right ventricular cardiomyopathy in pregnancy. Future Cardiol 2021;17:693-703. [PMID: 33089714 DOI: 10.2217/fca-2020-0127] [Reference Citation Analysis]
126 Lukas Laws J, Lancaster MC, Ben Shoemaker M, Stevenson WG, Hung RR, Wells Q, Marshall Brinkley D, Hughes S, Anderson K, Roden D, Stevenson LW. Arrhythmias as Presentation of Genetic Cardiomyopathy. Circ Res 2022;130:1698-722. [PMID: 35617362 DOI: 10.1161/CIRCRESAHA.122.319835] [Reference Citation Analysis]
127 Liżewska-Springer A, Królak T, Dorniak K, Kempa M, Dąbrowska-Kugacka A, Sławiński G, Lewicka E. Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis-Role of ICD. Int J Environ Res Public Health 2021;18:11631. [PMID: 34770146 DOI: 10.3390/ijerph182111631] [Reference Citation Analysis]
128 Segre EM, Hellwig LD, Turner C, Dobson CP, Haigney MC. Exercise Dose Associated With Military Service: Implications for the Clinical Management of Inherited Risk for Arrhythmogenic Right Ventricular Cardiomyopathy. Mil Med 2020;185:e1447-52. [PMID: 32666089 DOI: 10.1093/milmed/usaa185] [Reference Citation Analysis]
129 Wilde AAM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; Document Reviewers. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Heart Rhythm 2022:S1547-5271(22)01697-6. [PMID: 35390533 DOI: 10.1016/j.hrthm.2022.03.1225] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
130 Chen S, Zhang F, Wei Y, Lu X, Zhou G, Liu S. Alternating and gradually changing narrow QRS complex tachycardia in a patient with heart failure: What is the mechanism? Ann Noninvasive Electrocardiol 2021;26:e12836. [PMID: 33629476 DOI: 10.1111/anec.12836] [Reference Citation Analysis]
131 Cicenia M, Drago F. Arrhythmogenic Cardiomyopathy: Diagnosis, Evolution, Risk Stratification and Pediatric Population—Where Are We? JCDD 2022;9:98. [DOI: 10.3390/jcdd9040098] [Reference Citation Analysis]
132 Sinagra G, Cappelletto C, DE Luca A, Romani S, Paldino A, Korcova R, Ferro MD, Vitrella G, Pagnan L, Pinamonti B. Focus on arrhythmogenic right ventricular cardiomyopathy. Eur Heart J Suppl 2020;22:L129-35. [PMID: 33239987 DOI: 10.1093/eurheartj/suaa152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Merlo M, Grilli G, Cappelletto C, Masé M, Porcari A, Ferro MD, Gigli M, Stolfo D, Zecchin M, De Luca A, Mestroni L, Sinagra G. The Arrhythmic Phenotype in Cardiomyopathy. Heart Fail Clin 2022;18:101-13. [PMID: 34776072 DOI: 10.1016/j.hfc.2021.07.011] [Reference Citation Analysis]
134 Leopoulou M, Mattsson G, LeQuang JA, Pergolizzi JV, Varrassi G, Wallhagen M, Magnusson P. Naxos disease - a narrative review. Expert Rev Cardiovasc Ther 2020;18:801-8. [PMID: 32966140 DOI: 10.1080/14779072.2020.1828064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
135 Chowns J, Hoffman-andrews L, Marzolf A, Reza N, Owens AT. Cardiovascular Genetics. Medical Clinics of North America 2022. [DOI: 10.1016/j.mcna.2021.11.007] [Reference Citation Analysis]
136 Cannatà A, Merlo M, Dal Ferro M, Barbati G, Manca P, Paldino A, Graw S, Gigli M, Stolfo D, Johnson R, Roy D, Tharratt K, Bromage DI, Jirikowic J, Abbate A, Goodwin A, Rao K, Marawan A, Carr-White G, Robert L, Parikh V, Ashley E, McDonagh T, Lakdawala NK, Fatkin D, Taylor MRG, Mestroni L, Sinagra G. Association of Titin Variations With Late-Onset Dilated Cardiomyopathy. JAMA Cardiol 2022. [PMID: 35138330 DOI: 10.1001/jamacardio.2021.5890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
137 Robinson HK, Zaklyazminskaya E, Povolotskaya I, Surikova Y, Mallin L, Armstrong C, Mabin D, Benke PJ, Chrisant MR, McDonald M, Marboe CC, Agre KE, Deyle DR, McWalter K, Douglas G, Balashova MS, Kaimonov V, Shirokova N, Pomerantseva E, Turner CL, Ellard S. Biallelic variants in PPP1R13L cause paediatric dilated cardiomyopathy. Clin Genet 2020;98:331-40. [PMID: 32666529 DOI: 10.1111/cge.13812] [Reference Citation Analysis]
138 Costa C, Pinto R, Pinho T, Carvalho A, Cruz C, Madureira A, Macedo F. Dilated right cardiac chamber delusion solved by cardiovascular magnetic resonance. Cor Vasa 2021;63:741-2. [DOI: 10.33678/cor.2021.031] [Reference Citation Analysis]
139 Cheung CC, Roston T, Davies B, Grewal J, Laksman ZW, Krahn AD. Process of Care and a Practical Toolkit for Evaluating and Managing Arrhythmic Risk in the Cardiogenetic Pregnant Patient. Can J Cardiol 2021:S0828-282X(21)00647-4. [PMID: 34416260 DOI: 10.1016/j.cjca.2021.08.004] [Reference Citation Analysis]
140 Zhang X, Ye RY, Chen XP. Dilated left ventricle with multiple outpouchings — a severe congenital ventricular diverticulum or left-dominant arrhythmogenic cardiomyopathy: A case report. World J Clin Cases 2022; 10(18): 6289-6297 [DOI: 10.12998/wjcc.v10.i18.6289] [Reference Citation Analysis]
141 Porcari A, De Luca A, Grigoratos C, Biondi F, Faganello G, Vitrella G, Nucifora G, Aquaro GD, Merlo M, Sinagra G. Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle. Heart Fail Rev 2020. [PMID: 32564329 DOI: 10.1007/s10741-020-09986-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Casella M, Bergonti M, Dello Russo A, Maragna R, Gasperetti A, Compagnucci P, Catto V, Trombara F, Frappampina A, Conte E, Fogante M, Sommariva E, Rizzo S, De Gaspari M, Giovagnoni A, Andreini D, Pompilio G, Di Biase L, Natale A, Basso C, Tondo C. Endomyocardial Biopsy: The Forgotten Piece in the Arrhythmogenic Cardiomyopathy Puzzle. J Am Heart Assoc 2021;10:e021370. [PMID: 34569251 DOI: 10.1161/JAHA.121.021370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
143 Kaymakçalan Çelebiler H. Genetic counseling of ventricular tachycardias. Anatol J Cardiol 2021;25:675-6. [PMID: 34498603 DOI: 10.5152/AnatolJCardiol.2021.412] [Reference Citation Analysis]
144 Scheel PJ 3rd, Murray B, Tichnell C, James CA, Tandri H, Calkins H, Chelko SP, Gilotra NA. Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women. Am J Cardiol 2021;145:128-34. [PMID: 33460606 DOI: 10.1016/j.amjcard.2020.12.090] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
145 Lee HH, Ching CK. Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies. Clin Biochem Rev 2019;40:187-200. [PMID: 31857740 DOI: 10.33176/AACB-19-00030] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
146 Otto CM, Savla JJ, Hisama FM. Cardiogenetics: a primer for the clinical cardiologist. Heart 2020;106:938-47. [DOI: 10.1136/heartjnl-2019-316241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Bergonti M, Casella M, Compagnucci P, Russo AD, Tondo C. Electroanatomic Mapping System and Intracardiac-Echo to Guide Endomyocardial Biopsy. Card Electrophysiol Clin 2021;13:381-92. [PMID: 33990276 DOI: 10.1016/j.ccep.2021.02.005] [Reference Citation Analysis]
148 Martínez-Solé J, Sabater-Molina M, Braza-Boïls A, Santos-Mateo JJ, Molina P, Martínez-Dolz L, Gimeno JR, Zorio E. Facts and Gaps in Exercise Influence on Arrhythmogenic Cardiomyopathy: New Insights From a Meta-Analysis Approach. Front Cardiovasc Med 2021;8:702560. [PMID: 34733888 DOI: 10.3389/fcvm.2021.702560] [Reference Citation Analysis]
149 Mansueto G, Benincasa G, Capasso E, Graziano V, Russo M, Niola M, Napoli C, Buccelli C. Autoptic findings of sudden cardiac death (SCD) in patients with arrhythmogenic ventricular cardiomiopathy (AVC) from left ventricle and biventricular involvement. Pathology - Research and Practice 2020;216:153269. [DOI: 10.1016/j.prp.2020.153269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
150 James CA, Jongbloed JDH, Hershberger RE, Morales A, Judge DP, Syrris P, Pilichou K, Domingo AM, Murray B, Cadrin-Tourigny J, Lekanne Deprez R, Celeghin R, Protonotarios A, Asatryan B, Brown E, Jordan E, McGlaughon J, Thaxton C, Kurtz CL, van Tintelen JP. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. Circ Genom Precis Med 2021;14:e003273. [PMID: 33831308 DOI: 10.1161/CIRCGEN.120.003273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
151 Krittanawong C, Johnson KW, Choi E, Kaplin S, Venner E, Murugan M, Wang Z, Glicksberg BS, Amos CI, Schatz MC, Tang W. Artificial Intelligence and Cardiovascular Genetics. Life 2022;12:279. [DOI: 10.3390/life12020279] [Reference Citation Analysis]
152 Alreshq R, Tugal D, Siddiqi O, Ruberg F. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review. Pacing Clin Electrophysiol 2021;44:2092-9. [PMID: 34632598 DOI: 10.1111/pace.14375] [Reference Citation Analysis]
153 Ren J, Tsilafakis K, Chen L, Lekkos K, Kostavasili I, Varela A, Cokkinos DV, Davos CH, Sun X, Song J, Mavroidis M. Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy. Theranostics 2021;11:5939-54. [PMID: 33897891 DOI: 10.7150/thno.58160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Vogiatzi G, Lazaros G, Oikonomou E, Lazarou E, Vavuranakis E, Tousoulis D. Role of genetic testing in cardiomyopathies: Α primer for cardiologists. World J Cardiol 2022; 14(1): 29-39 [DOI: 10.4330/wjc.v14.i1.29] [Reference Citation Analysis]
155 Alturki A, Alotaibi B, Joza J, Proietti R. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Mechanisms and Management

]]>. RRCC 2020;Volume 11:19-29. [DOI: 10.2147/rrcc.s198185] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Moulson N, Isserow S, McKinney J. Lifestyle Considerations in Genetic Cardiac Conditions Associated with Sudden Cardiac Death. Can J Cardiol 2021:S0828-282X(21)00968-5. [PMID: 34979282 DOI: 10.1016/j.cjca.2021.12.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Heliö K, Kangas-Kontio T, Weckström S, Vanninen SUM, Aalto-Setälä K, Alastalo TP, Myllykangas S, Heliö TM, Koskenvuo JW. DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy. BMC Med Genet 2020;21:19. [PMID: 32005173 DOI: 10.1186/s12881-020-0955-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
158 Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER, Chugh SS, Cornel MC, Gardner K, Ingles J, James CA, Juang JJ, Kääb S, Kaufman ES, Krahn AD, Lubitz SA, MacLeod H, Morillo CA, Nademanee K, Probst V, Saarel EV, Sacilotto L, Semsarian C, Sheppard MN, Shimizu W, Skinner JR, Tfelt-Hansen J, Wang DW. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. J Arrhythm 2021;37:481-534. [PMID: 34141003 DOI: 10.1002/joa3.12449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Harris SL, Lubitz SA. Clinical and genetic evaluation after sudden cardiac arrest. J Cardiovasc Electrophysiol 2020;31:570-8. [PMID: 31909521 DOI: 10.1111/jce.14333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
160 Stern LK, Kittleson MM. Updates in Cardiac Amyloidosis Diagnosis and Treatment. Curr Oncol Rep 2021;23:47. [PMID: 33725199 DOI: 10.1007/s11912-021-01028-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Hammersley DJ, Jones RE, Mach L, Halliday BP, Prasad SK. Cardiovascular Magnetic Resonance in Heritable Cardiomyopathies. Heart Fail Clin 2021;17:25-39. [PMID: 33220885 DOI: 10.1016/j.hfc.2020.08.004] [Reference Citation Analysis]
162 Merlo M, Cannatà A, Pio Loco C, Stolfo D, Barbati G, Artico J, Gentile P, De Paris V, Ramani F, Zecchin M, Gigli M, Pinamonti B, Korcova R, Di Lenarda A, Giacca M, Mestroni L, Camici PG, Sinagra G. Contemporary survival trends and aetiological characterization in non‐ischaemic dilated cardiomyopathy. Eur J Heart Fail 2020;22:1111-21. [DOI: 10.1002/ejhf.1914] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
163 Moscarello T, Caleshu C. A Review of the Emergence and Expansion of Cardiovascular Genetic Counseling. Curr Cardiovasc Risk Rep 2019;13. [DOI: 10.1007/s12170-019-0631-z] [Reference Citation Analysis]
164 Brun F, Gigli M, Graw SL, Judge DP, Merlo M, Murray B, Calkins H, Sinagra G, Taylor MR, Mestroni L, James CA. FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy. J Med Genet 2020;57:254-7. [PMID: 31924696 DOI: 10.1136/jmedgenet-2019-106394] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
165 Gray B, Semsarian C. Utility of genetic testing in athletes. Clin Cardiol 2020;43:915-20. [PMID: 31925963 DOI: 10.1002/clc.23289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 27.0] [Reference Citation Analysis]
167 Scagliola R, Rosa GM, Seitun S. Cardiac Outpouchings: Definitions, Differential Diagnosis, and Therapeutic Approach. Cardiol Res Pract 2021;2021:6792643. [PMID: 34567801 DOI: 10.1155/2021/6792643] [Reference Citation Analysis]
168 Te Rijdt WP, Mieremet RHP, Kraaijenbrink T, Regieli JJ, Lemmink HH, Jan SZ, de Knijff P, Hoedemaekers YM. Deciduous Teeth as an Alternative DNA Source for Postmortem Genetic Testing. Circ Genom Precis Med 2020;13:e002674. [PMID: 32003586 DOI: 10.1161/CIRCGEN.119.002674] [Reference Citation Analysis]
169 Țentea CP, Eötvös CA, Lazar RD, Zehan IG, Paștiu G, Porca A, Jelnean M, Pop S, Blendea D. Integrating Electrocardiography and Vectorcardiography in the Differential Diagnosis of Wide Complex Tachycardia in a Patient with Left Ventricular Noncompaction: A Case Report and Brief Literature Review. Diagnostics (Basel) 2021;11:1152. [PMID: 34202450 DOI: 10.3390/diagnostics11071152] [Reference Citation Analysis]
170 Good JM, Fellmann F, Bhuiyan ZA, Rotman S, Pruvot E, Schläpfer J. ACTN2 variant associated with a cardiac phenotype suggestive of left-dominant arrhythmogenic cardiomyopathy. HeartRhythm Case Rep 2020;6:15-9. [PMID: 31956495 DOI: 10.1016/j.hrcr.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
171 Yuan ZY, Cheng LT, Wang ZF, Wu YQ. Desmoplakin and clinical manifestations of desmoplakin cardiomyopathy. Chin Med J (Engl) 2021;134:1771-9. [PMID: 34343150 DOI: 10.1097/CM9.0000000000001581] [Reference Citation Analysis]
172 McKenna WJ, Judge DP. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol 2021;18:22-36. [PMID: 32895535 DOI: 10.1038/s41569-020-0428-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
173 Lin YN, Ibrahim A, Marbán E, Cingolani E. Pathogenesis of arrhythmogenic cardiomyopathy: role of inflammation. Basic Res Cardiol 2021;116:39. [PMID: 34089132 DOI: 10.1007/s00395-021-00877-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Caimi-martinez F, Antoniutti G, Blanco R, García de la Villa B, Alvarenga N, Govea-callizo N, Torres-juan L, Heine-suñer D, Rosell-andreo J, Luengos DC, Alvarez-rubio J, Ripoll-vera T. New Variant in Placophilin-2 Gene Causing Arrhythmogenic Myocardiopathy. Genes 2022;13:782. [DOI: 10.3390/genes13050782] [Reference Citation Analysis]
175 Stevens TL, Wallace MJ, Refaey ME, Roberts JD, Koenig SN, Mohler PJ. Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design. J Cardiovasc Dev Dis 2020;7:E21. [PMID: 32466575 DOI: 10.3390/jcdd7020021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
176 Tayal U, Ware JS, Lakdawala NK, Heymans S, Prasad SK. Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. Eur Heart J 2021;42:2384-96. [PMID: 34153989 DOI: 10.1093/eurheartj/ehab286] [Reference Citation Analysis]
177 Ameri P, Schiattarella GG, Crotti L, Torchio M, Bertero E, Rodolico D, Forte M, Di Mauro V, Paolillo R, Chimenti C, Torella D, Catalucci D, Sciarretta S, Basso C, Indolfi C, Perrino C. Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology. Int J Mol Sci 2020;21:E1192. [PMID: 32054029 DOI: 10.3390/ijms21041192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
178 Wong JA, Roberts JD, Healey JS. The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape. Can J Cardiol 2021;37:644-54. [PMID: 33549824 DOI: 10.1016/j.cjca.2021.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
179 Leyton-Mange JS, Sze EY, Conley C, Vasaiwala SC, Sesselberg HW. Epicardial access facilitated by carbon dioxide insufflation for redo ventricular tachycardia ablation in a patient with arrhythmogenic right ventricular dysplasia and dense adhesions. HeartRhythm Case Rep 2021;7:197-202. [PMID: 34026494 DOI: 10.1016/j.hrcr.2020.12.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Sielemann K, Elbeck Z, Gärtner A, Brodehl A, Stanasiuk C, Fox H, Paluszkiewicz L, Tiesmeier J, Wlost S, Gummert J, Albaum SP, Sielemann J, Knöll R, Milting H. Distinct Myocardial Transcriptomic Profiles of Cardiomyopathies Stratified by the Mutant Genes. Genes (Basel) 2020;11:E1430. [PMID: 33260757 DOI: 10.3390/genes11121430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
181 Carruth ED, Young W, Beer D, James CA, Calkins H, Jing L, Raghunath S, Hartzel DN, Leader JB, Kirchner HL, Smelser DT, Carey DJ, Kelly MA, Sturm AC, Alsaid A, Fornwalt BK, Haggerty CM. Prevalence and Electronic Health Record-Based Phenotype of Loss-of-Function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Genes. Circ Genom Precis Med 2019;12:e002579. [PMID: 31638835 DOI: 10.1161/CIRCGEN.119.002579] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
182 Stolfo D, Cappelletto C. Reply to letter "The effect of beta-blocker on sudden cardiac death in arrhythmogenic right ventricle cardiomyopathy remains to be considered" by Zhenyu Dong et al. Int J Cardiol 2022:S0167-5273(22)00651-9. [PMID: 35525323 DOI: 10.1016/j.ijcard.2022.04.086] [Reference Citation Analysis]
183 Mizia-Stec K, Charron P, Gimeno Blanes JR, Elliott P, Kaski JP, Maggioni AP, Tavazzi L, Tendera M, Felix SB, Dominguez F, Ojrzynska N, Losi MA, Limongelli G, Barriales-Villa R, Seferovic PM, Biagini E, Wybraniec M, Laroche C, Caforio ALP; EORP Cardiomyopathy Registry Investigators. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry. Eur Heart J Cardiovasc Imaging 2021;22:781-9. [PMID: 33417664 DOI: 10.1093/ehjci/jeaa329] [Reference Citation Analysis]
184 Migliore F, Mattesi G, Zorzi A, Bauce B, Rigato I, Corrado D, Cipriani A. Arrhythmogenic Cardiomyopathy-Current Treatment and Future Options. J Clin Med 2021;10:2750. [PMID: 34206637 DOI: 10.3390/jcm10132750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
185 Casella M, Bergonti M, Narducci ML, Persampieri S, Gasperetti A, Conte E, Catto V, Carbucicchio C, Guerra F, Pontone G, Andreini D, Basso C, Di Biase L, Santangeli P, Natale A, Pelargonio G, Russo AD, Tondo C. Prior myocarditis and ventricular arrhythmias: The importance of scar pattern. Heart Rhythm 2021;18:589-96. [PMID: 33348060 DOI: 10.1016/j.hrthm.2020.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
186 Grace A, Calkins H, Ellenbogen K, Lambiase PD, Lip GY, Narayan SM, Katritsis DG. What Cannot Be Missed: Important Publications on Electrophysiology in 2019. Arrhythm Electrophysiol Rev 2020;9:4. [PMID: 32637112 DOI: 10.15420/aer.2020.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Finocchiaro G, Merlo M, Sheikh N, De Angelis G, Papadakis M, Olivotto I, Rapezzi C, Carr‐white G, Sharma S, Mestroni L, Sinagra G. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail 2020;22:1097-107. [DOI: 10.1002/ejhf.1815] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
188 Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci 2021;22:7722. [PMID: 34299342 DOI: 10.3390/ijms22147722] [Reference Citation Analysis]
189 Landry CH, Fatah M, Connelly KA, Angaran P, Hamilton RM, Dorian P. Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes. CJC Open 2021;3:498-503. [PMID: 34027353 DOI: 10.1016/j.cjco.2020.12.011] [Reference Citation Analysis]
190 Akintoye E, Ashwath ML. Cardiac magnetic resonance imaging findings in primary arrhythmogenic left ventricular cardiomyopathy with cardiocutaneous phenotype-Carvajal syndrome. HeartRhythm Case Rep 2021;7:312-5. [PMID: 34026522 DOI: 10.1016/j.hrcr.2021.01.024] [Reference Citation Analysis]
191 Zulfiqar S, Moawia A, Waseem SS, Ali Z, Ramzan S, Anjum I, Baig SM, Tariq M. Whole exome sequencing identifies a novel variant causing Cockayne syndrome Type I in a consanguineous Pakistani family. International Journal of Neuroscience. [DOI: 10.1080/00207454.2022.2082967] [Reference Citation Analysis]
192 Pendela VS, Kudaravalli P, Feitell S, Parikh V. Cardiac sarcoidosis masquerading as arrhythmogenic right ventricular cardiomyopathy: a case report. Eur Heart J Case Rep 2021;5:ytab072. [PMID: 34113762 DOI: 10.1093/ehjcr/ytab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Corrado D, van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A, Basso C, Bauce B, Brunckhorst C, Bucciarelli-Ducci C, Duru F, Elliott P, Hamilton RM, Haugaa KH, James CA, Judge D, Link MS, Marchlinski FE, Mazzanti A, Mestroni L, Pantazis A, Pelliccia A, Marra MP, Pilichou K, Platonov PGA, Protonotarios A, Rampazzo A, Saffitz JE, Saguner AM, Schmied C, Sharma S, Tandri H, Te Riele ASJM, Thiene G, Tsatsopoulou A, Zareba W, Zorzi A, Wichter T, Marcus FI, Calkins H; International Experts. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J 2020;41:1414-29. [PMID: 31637441 DOI: 10.1093/eurheartj/ehz669] [Cited by in Crossref: 23] [Cited by in F6Publishing: 38] [Article Influence: 23.0] [Reference Citation Analysis]
194 Wilde AAM, Semsarian C, Márquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA, Sternick EB, Barajas-Martinez H, Behr ER, Bezzina CR, Breckpot J, Charron P, Chockalingam P, Crotti L, Gollob MH, Lubitz S, Makita N, Ohno S, Ortiz-Genga M, Sacilotto L, Schulze-Bahr E, Shimizu W, Sotoodehnia N, Tadros R, Ware JS, Winlaw DS, Kaufman ES; ESC Scientific Document Group . European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace 2022:euac030. [PMID: 35373836 DOI: 10.1093/europace/euac030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
195 John RM, Stern DL. Use of Implantable Electronic Devices in Patients With Cardiac Amyloidosis. Can J Cardiol 2020;36:408-15. [PMID: 32037105 DOI: 10.1016/j.cjca.2019.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
196 El Masri I, Kayali SM, Blount C, Kirolos I, Khouzam JP, Kabra R. Is Exercise Helpful or Harmful in Dealing With Specific Arrhythmia. Curr Probl Cardiol 2021;46:100740. [PMID: 33213943 DOI: 10.1016/j.cpcardiol.2020.100740] [Reference Citation Analysis]
197 Protonotarios A, Elliott PM. Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype? Eur Cardiol 2020;15:1-5. [PMID: 32180838 DOI: 10.15420/ecr.2019.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
198 Shah RA, Asatryan B, Dabbagh GS, Aung N, Khanji MY, Lopes LR, van Duijvenboden S, Holmes A, Muser D, Landstrom AP, Lee AM, Arora P, Semsarian C, Somers VK, Owens AT, Munroe PB, Petersen SE, Chahal CAA. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. Circulation 2022;:101161CIRCULATIONAHA121058143. [PMID: 35708014 DOI: 10.1161/CIRCULATIONAHA.121.058143] [Reference Citation Analysis]
199 Sinagra G, Elliott PM, Merlo M. Dilated cardiomyopathy: so many cardiomyopathies! European Heart Journal 2020;41:3784-6. [DOI: 10.1093/eurheartj/ehz908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
200 Chen S, Chen L, Duru F, Hu S. Heart Failure in Patients with Arrhythmogenic Cardiomyopathy. J Clin Med 2021;10:4782. [PMID: 34682905 DOI: 10.3390/jcm10204782] [Reference Citation Analysis]
201 James CA, Syrris P, van Tintelen JP, Calkins H. The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. European Heart Journal 2020;41:1393-400. [DOI: 10.1093/eurheartj/ehaa141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
202 Monda E, Palmiero G, Rubino M, Verrillo F, Amodio F, Di Fraia F, Pacileo R, Fimiani F, Esposito A, Cirillo A, Fusco A, Moscarella E, Frisso G, Russo MG, Pacileo G, Calabrò P, Scudiero O, Caiazza M, Limongelli G. Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies. Int J Mol Sci 2020;21:E6462. [PMID: 32899712 DOI: 10.3390/ijms21186462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
203 Roudijk RW, Taha K, Bourfiss M, Loh P, van den Heuvel L, Boonstra MJ, van Lint F, van der Voorn SM, Te Riele ASJM, Bosman LP, Christiaans I, van Veen TAB, Remme CA, van den Berg MP, van Tintelen JP, Asselbergs FW. Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium. Neth Heart J 2021;29:301-8. [PMID: 33528799 DOI: 10.1007/s12471-021-01542-1] [Reference Citation Analysis]
204 Eberly L, Garg L, Vidula M, Reza N, Krishnan S. Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy. Curr Treat Options Cardiovasc Med 2021;23:64. [PMID: 35082480 DOI: 10.1007/s11936-021-00943-0] [Reference Citation Analysis]
205 Ureche C, Sascău RA, Stătescu C. In search of lost time - a case of myocardial perforation in a patient with arrhythmogenic right ventricular cardiomyopathy. Arch Clin Cases 2019;6:96-102. [PMID: 34754916 DOI: 10.22551/2019.25.0604.10161] [Reference Citation Analysis]
206 Laredo M, Oliveira Da Silva L, Extramiana F, Lellouche N, Varlet É, Amet D, Algalarrondo V, Waintraub X, Duthoit G, Badenco N, Maupain C, Hidden-lucet F, Maury P, Gandjbakhch E. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2020;17:41-8. [DOI: 10.1016/j.hrthm.2019.06.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
207 Yogasundaram H, Alhumaid W, Dzwiniel T, Christian S, Oudit GY. Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management. Can J Cardiol. 2021;. [PMID: 33493662 DOI: 10.1016/j.cjca.2021.01.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Costa S, Medeiros-Domingo A, Gasperetti A, Akdis D, Berger W, James CA, Ruschitzka F, Brunckhorst CB, Duru F, Saguner AM. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria. Circ Genom Precis Med 2021;14:e003047. [PMID: 33232181 DOI: 10.1161/CIRCGEN.120.003047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
209 Cappelletto C, Gregorio C, Barbati G, Romani S, De Luca A, Merlo M, Mestroni L, Stolfo D, Sinagra G. Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy. Int J Cardiol 2021;334:58-64. [PMID: 33961942 DOI: 10.1016/j.ijcard.2021.04.069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Zhang K, Cloonan PE, Sundaram S, Liu F, Das SL, Ewoldt JK, Bays JL, Tomp S, Toepfer CN, Marsiglia JDC, Gorham J, Reichart D, Eyckmans J, Seidman JG, Seidman CE, Chen CS. Plakophilin-2 truncating variants impair cardiac contractility by disrupting sarcomere stability and organization. Sci Adv 2021;7:eabh3995. [PMID: 34652945 DOI: 10.1126/sciadv.abh3995] [Reference Citation Analysis]
211 Prior D, La Gerche A. Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy. Heart Lung Circ. 2020;29:547-555. [PMID: 31964580 DOI: 10.1016/j.hlc.2019.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
212 Li Z, Wang Y, Li L, He H, Lin L, Pan M, Yang T, Liu Q. A bibliometric analysis of the cause of sudden unexplained death in forensic medicine: Research trends, hot spots and prospects. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Przybylski R, Abrams DJ. Clinical and genetic features of arrhythmogenic cardiomyopathy: the electrophysiology perspective. Progress in Pediatric Cardiology 2021;63:101463. [DOI: 10.1016/j.ppedcard.2021.101463] [Reference Citation Analysis]
214 Groh WJ, Bhakta D, Tomaselli GF, Aleong RG, Teixeira RA, Amato A, Asirvatham SJ, Cha YM, Corrado D, Duboc D, Goldberger ZD, Horie M, Hornyak JE, Jefferies JL, Kääb S, Kalman JM, Kertesz NJ, Lakdawala NK, Lambiase PD, Lubitz SA, McMillan HJ, McNally EM, Milone M, Namboodiri N, Nazarian S, Patton KK, Russo V, Sacher F, Santangeli P, Shen WK, Sobral Filho DC, Stambler BS, Stöllberger C, Wahbi K, Wehrens XHT, Weiner MM, Wheeler MT, Zeppenfeld K. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. Heart Rhythm 2022:S1547-5271(22)01946-4. [PMID: 35500790 DOI: 10.1016/j.hrthm.2022.04.022] [Reference Citation Analysis]